US Veterinary Diagnostics Market Size Likely to Grow at a CAGR of 9.27% By 2034

Market Size and Growth

As per the US Veterinary Diagnostics Market size analysis conducted by the CMI team, the US veterinary diagnostics market is expected to record a CAGR of 9.27% from 2025 to 2034. In 2025, the market size was USD 5.17 Billion. By 2034, the valuation is anticipated to reach USD 11.44 Billion.

Overview

As per the industry experts at CMI, the U.S. veterinary diagnostics market is poised to witness a staggering CAGR during the forecast period. This could be attributed to a rise in awareness regarding animal health, increased frequency of pet ownership, and various advancements in diagnostic technologies. The market is known for its strong focus on the adoption of innovations such as AI-driven diagnostics and POC testing and preventive care. Increase in the number of pet owners, especially in the U.S., does drive the demand for diagnostic testing and veterinary services. Also, developments in imaging systems, molecular diagnostics, and rapid testing kits are improving the efficiency and precision of veterinary diagnostics.

Key Trends & Drivers

• Rise in Demand for Livestock Diagnostics to Determine Growth: With the rise in demand for animal-derived food products, there is an increasing emphasis on ascertaining the well-being and health of livestock. Diagnosing diseases at an early stage with utmost precision is essential in order to prevent outbreaks, thereby minimizing monetary losses for farmers and maintaining the confidence of consumers regarding the safety of the food supply. Also, increasing incidences of zoonotic diseases such as African swine fever and avian influenza have raised the awareness pertaining to the vitality of veterinary diagnostics.

• Government Funding and Support to Catalyze the U.S. Veterinary Diagnostics Market: The U.S. veterinary diagnostics market is witnessing replenishment in the form of a higher rate of pet ownership. Research states that over 60% of the U.S. households own a pet. The government has come forward through USDA funding in order to improve early diagnosis capabilities for animal diseases. It has also proposed conducive reimbursements related to the establishment of new laboratories.

Report Scope

Feature of the Report	Details
Market Size in 2025	USD 5.17 Billion
Projected Market Size in 2034	USD 11.44 Billion
Market Size in 2024	USD 4.73 Billion
CAGR Growth Rate	9.27% CAGR
Base Year	2024
Forecast Period	2025-2034
Key Segment	By Product, Testing Category, Animal Type, End-use and Region
Report Coverage	Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends
Regional Scope	North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America
Buying Options	Request tailored purchasing options to fulfil your requirements for research.

SWOT Analysis

• Strengths: Rise in the number of pet owners coupled with continual innovation in diagnostic technologies encompassing imaging, molecular diagnostics, and POC testing is enhancing the speed of diagnosis. The pet owners are also increasingly spending on advanced diagnostic services and veterinary care in the wake of growing awareness regarding animal care, thereby fueling the growth of the market further.

• Weaknesses: Advanced diagnostic equipment could be expensive, which could compel low-budget pet owners to give a second thought regarding opting for it. Also, stern regulations for product approvals and diagnostic testing could create barriers to entry into the market for new players. Besides, using digital technologies in diagnostics could raise concerns regarding pets' privacy amongst pet owners.

• Opportunities: Rise in frequency of humanization of pets and popularity of companion animals are likely to offer lucrative opportunities to the U.S. veterinary diagnostics market. Furthermore, rising incidences of cancer among pets are driving the market for U.S. veterinary oncology diagnostics. Strategic partnerships and collaborations between the market players could also be likely to drive the market.

• Threats: Alterations in prices of raw materials used in the diagnostic tests could impact revenue generation on the part of players. Furthermore, speedy technological advancements could render the existing diagnostic tools obsolete, thereby asking the players to innovate on a continuous basis. These are some of the threats to the U.S. veterinary diagnostics market.

List of the prominent players in the US Veterinary Diagnostics Market:

• IDEXX Laboratories Inc.
• Zoetis Services LLC
• Thermo Fisher Scientific Inc.
• Antech Diagnostics Inc.
• Neogen Corporation
• Bio-Rad Laboratories Inc.
• Heska Corporation
• Chembio Diagnostic Systems Inc.
• Abbott Laboratories
• Danaher Corporation
• Creative Diagnostics
• General Electric
• Others

The US Veterinary Diagnostics Market is segmented as follows:

By Product

• Consumables
• Reagents
• Kits
• Equipment & Instruments

By Testing Category

• Clinical Chemistry
• Microbiology
• Parasitology
• Histopathology
• Cytopathology
• Hematology
• Immunology & Serology
• Imaging
• Molecular Diagnostics

By Animal Type

• Production Animals
• Cattle
• Poultry
• Swine
• Companion Animals
• Dogs
• Cats
• Horses

By End-use

• Reference Laboratories
• Veterinarians
• Animal Owners/Producers